Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patientsBECOUARN, Y; YCHOU, M; DUFFOUR, J et al.Journal of clinical oncology. 1998, Vol 16, Num 8, pp 2739-2744, issn 0732-183XArticle

Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patientsSEITZ, J.-F; BENNOUNA, J; NASCA, S et al.Annals of oncology. 2002, Vol 13, Num 7, pp 1072-1079, issn 0923-7534Article

Combination raltitrexed (Tomudex®)-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesotheliomaFIZAZI, K; CALIANDRO, R; LE CHEVALIER, T et al.European journal of cancer (1990). 2000, Vol 36, Num 12, pp 1514-1521, issn 0959-8049Article

A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinomaRINI, B; REDMAN, B; GARCIA, J. A et al.Annals of oncology. 2014, Vol 25, Num 9, pp 1794-1799, issn 0923-7534, 6 p.Article

Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal typeFANDI, A; BACHOUCHI, M; AZLI, N et al.Journal of clinical oncology. 2000, Vol 18, Num 6, pp 1324-1330, issn 0732-183XConference Paper

Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatinDUCREUX, M; ROUGIER, P; FANDI, A et al.Annals of oncology. 1998, Vol 9, Num 6, pp 653-656, issn 0923-7534Article

Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: Results of a phase II studyFIZAZI, K; DOUBRE, H; LE CHEVALIER, T et al.Journal of clinical oncology. 2003, Vol 21, Num 2, pp 349-354, issn 0732-183X, 6 p.Article

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal typeTAAMMA, A; FANDI, A; AZLI, N et al.Cancer. 1999, Vol 86, Num 7, pp 1101-1108, issn 0008-543XArticle

Carcinomes indifférenciées du nasopharynx : aspects épidémiologique, clinique et thérapeutique = Undifferentiated carcinoma of the nasopharynx. Epidemiological, clinical and therapeutical aspectsFANDI, A; YANES, B; TAAMMA, A et al.Bulletin du cancer. 1994, Vol 81, Num 7, pp 571-586, issn 0007-4551Article